Rino Rappuoli

Dr_Rino_Rappuoli_ForMemRS_(cropped)

Rino Rappuoli

Rino Rappuoli is an Italian immunologist and vaccinologist known for his significant contributions to the field of vaccinology. He is currently the Chief Scientist and Head of External Research and Development (R&D) at GlaxoSmithKline Vaccines.

Early Life and Education

Rino Rappuoli was born in Italy and obtained his Ph.D. in Biological Sciences from the University of Siena.

Career

Rappuoli has made groundbreaking advancements in the development of vaccines, particularly in the areas of reverse vaccinology and adjuvants. He has been instrumental in the creation of several vaccines that have had a profound impact on global health.

One of his most notable achievements is the development of a vaccine for meningococcus B using reverse vaccinology, a technique he pioneered. This vaccine has been successful in preventing meningitis outbreaks in various parts of the world.

Rappuoli has also been involved in the development of adjuvants, substances that enhance the body's immune response to vaccines. His work in this area has led to the creation of more effective and long-lasting vaccines.

Awards and Recognition

Rino Rappuoli's contributions to the field of vaccinology have been widely recognized. He has received numerous awards, including the Albert B. Sabin Gold Medal from the Sabin Vaccine Institute.

Legacy

Rappuoli's work continues to have a lasting impact on global health, with his vaccines saving countless lives around the world.

References

‎